ZBH Zimmer Biomet Total Asset Value of Company

Official company branding of zimmerbiomet.com (ZBH)

Zimmer Biomet Holdings (ZBH) develops high-tech implants and robotics for clinics, targeting the aging populations of developed nations. The business relies on a loyal workforce of engineers and R&D specialists in digital planning. Demand for joint surgery is non-cyclical and protected by insurance. This price chart confirms the growth of total assets, which currently stand at 22849.86, demonstrating the company's resilience to external shocks.

Company Total Assets: Zimmer Biomet Holdings (ZBH) for 07/04/2022 - 11/01/2026

Financial and market metric breakdowns for Zimmer Biomet (ZBH)

- current quotes and average value forecast:
Market Chart Zimmer Biomet Holdings|ZBH - Price Target Chart
- market capitalization data:
Market Valuation Zimmer|ZBH - Enterprise Value
- issuer book value statistics:
Net Asset Value per Share Zimmer Biomet|ZBH - Book Capitalization|Market Cap to Net Assets Ratio zimmerbiomet.com|ZBH - Company Total Assets
- debt burden and liquidity indicators:
Total Debt to Capital Coefficient Zimmer Biomet Holdings|ZBH - Long-Term Debt to Capital|Short-Term Debt to Capital Zimmer Biomet Holdings, Inc.|ZBH - Company Debts|Debt to Book Capitalization Ratio Zimmer|ZBH - Company Long-Term Debts|Short-Term Debt Volume Zimmer Biomet|Critical Liquidity Ratio zimmerbiomet.com
- company profitability and valuation multiples indicators:
ZBH - Net Profit
Basic company analysis:Zimmer Biomet Corp, ZBH
Mass-produced product of Zimmer Biomet

The implementation of the ROSA system and AI analytics requires significant capital expenditures in the technological base. The level of consolidated assets, calculated inversely via ROA, reflects the total value of resources and liabilities of Zimmer Biomet (ZBH). This trend captures the efficiency of capital utilization for business scaling. The growing trend confirms the expansion of production capacities, which directly impacts the fundamental value and market capitalization of the issuer.

Direct competitors

BSX - Company Total Asset Base|Aggregate Company Assets Edwards Lifesciences Corporation|ResMed Inc - Total Asset Value of Company|Company Total Assets PODD|COO - Company Assets|Company Total Assets ALGN (Align Technology, Inc.)|GMED - Cumulative Company Assets|TransMedics Group - Company Total Assets|Company Total Asset Base Alphatec Holdings ATEC|AORT: Company Total Assets|Enovis Inc. (ENOV) - Company Total Assets|Aggregate Company Assets Integra LifeSciences|Aggregate Company Assets ESTA|Company Total Assets BBNX|Company Total Asset Base IRADIMED Corp|Embecta Inc. - Cumulative Company Assets|TNDM (Tandem Corp) - Total Asset Value of Company|AxoGen, Inc. - Company Total Assets|Company Assets si-bone.com|OFIX: Company Total Assets|Total Business Assets BVS|Cumulative Company Assets KIDS|TMCI: Aggregate Asset Value|Aggregate Company Assets Strata Critical Medical Inc (SRTA)|Cumulative Company Assets carlsmed.com CARL|Company Total Assets RXST (RxSight)|ClearPoint Neuro Inc. (CLPT) - Company Assets|Stereotaxis Corp - Company Total Assets|STIM (Neuronetics, Inc) - Total Business Assets|SGHT: Company Total Assets|OBIO - Company Total Asset Base|ANIK (Anika Therapeutics Inc.) - Company Total Assets|Cumulative Company Assets InspireMD Inc (NSPR)|Company Total Assets ZJYL|Company Total Assets vivani.com (VANI)|Aggregate Company Assets Xtant Medical XTNT|n1mtc.com - Aggregate Company Assets|MODD: Cumulative Company Assets|Aggregate Asset Value MYO (Myomo Inc.)|COCH: Company Total Assets|Company Assets Vivos Therapeutics Inc (VVOS)|Aggregate Company Assets enVVeno Medical|SINT - Company Balance Sheet Assets|Cumulative Company Assets TNON (Tenon Medical)|Company Total Assets ReWalk Robotics (LFWD)|Company Total Assets AMIX (Autonomix Medical)|Company Total Asset Base INVO Fertility Corp (IVF)|BBLG - Aggregate Company Assets|Total Asset Value of Company AXNX|BIOLASE (BIOL) - Aggregate Company Assets|Cumulative Company Assets Dynatronics|FNA (Paragon 28 Inc.) - Company Total Assets|Company Assets INVO Bio INVO